1. ANTIGEN PROCESSING AND PRESENTATION 1. Mechanisms of antigen processing and presentation. 2. How cellular and molecular interactions in antigen processing lead to activation of T cell immunity.
2.
3. Antigen (HEL) bound to the Fab portion of Anti-HEL Antibody. Fab: antigen binding fraction of antibody
4. T CELLS ( IN CONTRAST TO B CELLS ) RECOGNIZE AN ANTIGEN ONLY WHEN ITS FRAGMENT IS BOUND WITHIN THE GROOVE OF MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) MOLECULE
5. T CELLS RECOGNIZE AN ANTIGEN ONLY WHEN ITS FRAGMENT IS BOUND WITHIN MHC GROOVE Peptide-MHC Class II complex
7. 1. A central event in generation of both humoral and cell-mediated immune response is activation of helper T lymphocytes. 2. T lymphocytes interact with specific antigen via their T cell receptors. 3. T cell receptors are unable to recognize a soluble antigen. Why do antigens need to be processed and presented in order to activate an immune response ?
8.
9. Antigen = any molecule or pathogen that stimulates an immune response. e.g., pathogen proteins or carbohydrates foreign to host. Antigen processing = degradation of pathogens and proteins into peptides that can bind to MHC molecules for presentation to T cells. Antigen Presenting cells (APC) =highly specialized cells that can process antigens and display their peptide fragments on the cell surface together with molecules required for T cell activation. The main APCs for T cells are dendritic cells, macrophages, and B cells . MHC class I and II = Major Histocompatibility Complex class I and II, a set of highly polymorphic membrane glycoproteins that present peptides to T cells. The recognition of MHC molecules loaded with pathogen-derived peptides by T cells initiates the immune response. Short Glossary
10. Steps involved in Antigen Processing and presentation 1. Fragmentation of pathogens into proteins and then into peptides 2. Association of peptides with an MHC molecule 3. Transport to cell surface for expression. 4. Different cellular pathways exist for association of peptides with either MHC Class I or class II molecules.
14. 6. Pathogens/antigens that are either synthesized (e.g. viral proteins) or reside within the cytoplasm are processed and presented via the Endogenous Pathway of antigen presentation. Exogenous and Endogenous Antigens and Pathways of Antigen Presentation
15. The peptides produced in the Endocytic Pathway are brought to the cell surface by MHC class II molecules and are displayed to CD4 T cells. The Endocytic Pathway of antigen presentation is thus responsible for antigen specific activation of CD4 T helper cells. Exogenous (or endocytic) Pathway of Antigen Presentation
16. Endogenous Pathway of Antigen Presentation The peptides produced in the Endogenous Pathway are brought to the cell surface by MHC class I molecules and are displayed to CD8 T cells. The Endogenous Pathway of antigen presentation is thus responsible for antigen specific activation of CD8 T cytotoxic cells. The antigens in this pathway are usually those that happen to be produced in the cytosol or reside in the cytosol.
18. Antigen Presenting Cells (APC) APC are cells that degrade the foreign antigen into peptides. After active metabolic processing of antigens, they present the peptides within the antigen binding grooves of either class I or MHC class II molecules. They provide a co-stimulatory signal to T cells for activation. Professional antigen presenting cells: Constitutively express high amounts of MHC molecules (especially MHC class II molecules), and co-stimulatory molecules, e.g. dendritic cells. Target cells : APC expressing MHC class I bound antigenic peptides to cytotoxic CD8 T cells are often called target cells. All cells can be target cells. Professional APC are extremely efficient target cells due to effective co-stimulation.
22. Facultative Antigen Presenting Cells Phagocytosis Type Location Class II expression + astrocytes brain inducible follicular cells thyroid inducible -/+ endothelium vascular and - to inducible(++) lymphoid tissue fibroblasts connective tissue - to inducible (++) These can be induced to present antigens
23. MHC class II pathway (exogenous pathway) of antigen processing
24. The Endocytic (Exogenous) Pathway of antigen Presentation Leads to presentation of MHC II bound peptides to CD4 T cells. Antigen is processed within the endocytic vesicles. MHC II traffics through the endocytic pathway and binds antigenic peptides enroute to the cell surface of an APC.
30. Antigen presentation by B cells: the same as other APC except B cells take up antigen via Ig receptors and are thus can be more efficient.
31. MHC class I pathway (endogenous pathway) of antigen presentation
32. The Endogenous Pathway of antigen Presentation Leads to presentation MHC I bound peptides to CD8 T cells. Antigen is processed within the cytosol (proteasomes). Processed peptides are transported across the ER membrane. MHC I-peptide complexes are formed in the ER and traffic through the conventional secretory pathway to eventually be expressed on the cell surface.
33.
34. MHC class I pathway Peptides for transport into ER are generated in cytosol by degradation carried out by a large multicatalytic protease complex-PROTEASOME The structure of proteasome
35. Peptides that bind to MHC class I molecules are actively transported from the cytosol to the ER. Transporters associated with Antigen Processing (TAP) TAP1 and TAP2 form a peptide transporter in the ER membrane. Mutations in either gene can prevent Ag presentation by MHC I.
38. Co-stimulatory and adhesion molecules required for successful T cell-APC interactions. Lymphocyte Activation
39. Absolute requirement for activation of T helper cells leading to cytokine production: (i) Specific interaction of TCR with MHC II-peptide complex and (ii) non-specific interaction of CD28 with B7 molecules.
40. CD4 T helper cells can be separated into 2 different subsets of T helper cells: T H 1 and T H 2 depending on the set of cytokines they secrete.
41. CONCLUSIONS Pathogens and antigens need to be partially degraded into peptides before they bind MHC molecules and are presented on the surface of an APC. Newly synthesized MHC molecules traffic through either the endocytic pathway (MHC class II) or the conventional secretory pathway (MHC class I) and bind the antigen derived peptide enroute to the cell surface. At a minimum, activation of T cells requires a specific signal via the TCR-MHC-peptide complex and a non-specific signal via CD28-B7 molecules.
